{
  "科技创新公司": {
    "company_info": {
      "industry": "科技",
      "founded": "2015",
      "employees": 1200,
      "description": "专注于人工智能和云计算的科技公司"
    },
    "financial_metrics": {
      "revenue": 1500000000,
      "net_income": 180000000,
      "total_assets": 8000000000,
      "total_liabilities": 3000000000,
      "shareholders_equity": 5000000000,
      "current_assets": 4000000000,
      "current_liabilities": 1500000000,
      "cash_and_equivalents": 2000000000,
      "operating_cash_flow": 250000000,
      "gross_margin": 0.65,
      "net_margin": 0.12,
      "roe": 0.036,
      "roa": 0.0225,
      "current_ratio": 2.67,
      "debt_to_equity": 0.6,
      "historical_revenue": [
        1000000000,
        1200000000,
        1350000000,
        1500000000
      ],
      "historical_net_income": [
        100000000,
        140000000,
        160000000,
        180000000
      ],
      "historical_years": [
        "2020",
        "2021",
        "2022",
        "2023"
      ]
    },
    "risk_indicators": {
      "liquidity_risk": "low",
      "profitability_trend": "improving",
      "debt_level": "moderate",
      "cash_position": "strong"
    }
  },
  "传统制造企业": {
    "company_info": {
      "industry": "制造业",
      "founded": "1995",
      "employees": 3500,
      "description": "大型机械制造企业，产品出口全球"
    },
    "financial_metrics": {
      "revenue": 2200000000,
      "net_income": 110000000,
      "total_assets": 12000000000,
      "total_liabilities": 8000000000,
      "shareholders_equity": 4000000000,
      "current_assets": 5000000000,
      "current_liabilities": 3000000000,
      "cash_and_equivalents": 800000000,
      "operating_cash_flow": 180000000,
      "gross_margin": 0.35,
      "net_margin": 0.05,
      "roe": 0.0275,
      "roa": 0.0092,
      "current_ratio": 1.67,
      "debt_to_equity": 2.0,
      "historical_revenue": [
        1800000000,
        1950000000,
        2100000000,
        2200000000
      ],
      "historical_net_income": [
        80000000,
        95000000,
        105000000,
        110000000
      ],
      "historical_years": [
        "2020",
        "2021",
        "2022",
        "2023"
      ]
    },
    "risk_indicators": {
      "liquidity_risk": "medium",
      "profitability_trend": "stable",
      "debt_level": "high",
      "cash_position": "adequate"
    }
  },
  "新兴生物医药": {
    "company_info": {
      "industry": "生物医药",
      "founded": "2018",
      "employees": 800,
      "description": "专注于创新药物研发的生物医药公司"
    },
    "financial_metrics": {
      "revenue": 500000000,
      "net_income": -50000000,
      "total_assets": 3000000000,
      "total_liabilities": 800000000,
      "shareholders_equity": 2200000000,
      "current_assets": 2000000000,
      "current_liabilities": 400000000,
      "cash_and_equivalents": 1500000000,
      "operating_cash_flow": -80000000,
      "gross_margin": 0.8,
      "net_margin": -0.1,
      "roe": -0.023,
      "roa": -0.017,
      "current_ratio": 5.0,
      "debt_to_equity": 0.36,
      "historical_revenue": [
        100000000,
        250000000,
        380000000,
        500000000
      ],
      "historical_net_income": [
        -80000000,
        -70000000,
        -60000000,
        -50000000
      ],
      "historical_years": [
        "2020",
        "2021",
        "2022",
        "2023"
      ]
    },
    "risk_indicators": {
      "liquidity_risk": "low",
      "profitability_trend": "improving_losses",
      "debt_level": "low",
      "cash_position": "excellent"
    }
  }
}